Your browser doesn't support javascript.
loading
[Aucubin combined with ADSCs-exos protects TBHP-induced nucleus pulposus cells via TLR4/NF-κB pathway].
Yang, Lei; Li, Zhao-Yong; Ma, Lu; Guo, Yan-Tao; Yang, Shao-Feng; Xiong, Hui; Wu, Bo-Yu; Duan, Jia-Hao; Liu, En-Xu; Zhang, Chao; Nie, Ying; Chen, Long; Liu, Lin-Quan.
Afiliación
  • Yang L; the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
  • Li ZY; the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
  • Ma L; Hunan University of Chinese Medicine Changsha 410208, China.
  • Guo YT; the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
  • Yang SF; the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
  • Xiong H; Hunan University of Chinese Medicine Changsha 410208, China.
  • Wu BY; Hunan University of Chinese Medicine Changsha 410208, China.
  • Duan JH; the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
  • Liu EX; the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
  • Zhang C; the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
  • Nie Y; the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
  • Chen L; the First Affiliated Hospital of Hunan University of Chinese Medicine Changsha 410007, China.
  • Liu LQ; Hunan University of Chinese Medicine Changsha 410208, China.
Zhongguo Zhong Yao Za Zhi ; 48(19): 5294-5303, 2023 Oct.
Article en Zh | MEDLINE | ID: mdl-38114119
ABSTRACT
This paper aims to investigate the effects and mechanisms of adipose-derived stem cells-exosomes(ADSCs-exos) toge-ther with aucubin in protecting human-derived nucleus pulposus cells(NPCs) from inflammatory injury, senescence, and apoptosis. The tert-butyl hydroperoxide(TBHP)-induced NPCs were assigned into normal, model, aucubin, ADSCs-exos, and aucubin+ADSCs-exos groups. The cell viability was examined by cell counting kit-8(CCK-8), cell proliferation by EdU staining, cell senescence by senescence-associated-ß-galactosidase(SA-ß-Gal), and cell cycle and apoptosis by flow cytometry. Enzyme-linked immunosorbent assay was employed to examine the expression of interleukin-1ß(IL-1ß), IL-10, and tumor necrosis factor-α(TNF-α). Real-time fluorescence quantitative PCR and Western blot were employed to determine the mRNA and protein levels of aggregated proteoglycan(aggrecan), type Ⅱ collagen alpha 1(COL2A1), Toll-like receptor 4(TLR4), and nuclear factor-kappa B(NF-κB). The results showed that compared with the model group, the aucubin or ADSCs-exos group showed enhanced viability and proliferation of NPCs, decreased proportion of G_0/G_1 phase cells, increased proportion of S phase cells, reduced apoptosis and proportion of cells in senescence, lowered IL-1ß and TNF-α levels, elevated IL-10 level, down-regulated mRNA and protein levels of TLR4 and NF-κB, and up-regulated mRNA and protein levels of aggrecan and COL2A1. Compared with the aucubin or ADSCs-exos group, the aucubin+ADSCs-exos combination further increased the viability and proliferation of NPCs, decreased the proportion of G_0/G_1 phase cells, increased the proportion of S phase cells, reduced the apoptosis and proportion of cells in senescence, lowered the IL-1ß and TNF-α levels, elevated the IL-10 level, down-regulated the mRNA and protein levels of TLR4 and NF-κB, and up-regulated the mRNA and protein levels of aggrecan and COL2A1. In summary, both aucubin and ADSCs-exos could exert protective effects by inhibiting inflammatory responses, reducing apoptosis and senescence of NPCs, improving cell viability and proliferation as well as extracellular matrix synthesis, which may be associated with the inhibition of TLR4/NF-κB signaling pathway activation. The combination of both plays a synergistic role in the protective effects.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: FN-kappa B / Núcleo Pulposo Límite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: FN-kappa B / Núcleo Pulposo Límite: Humans Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Asunto de la revista: FARMACOLOGIA / TERAPIAS COMPLEMENTARES Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China